Ectodermal Dysplasia, Hypohidrotic, X-Linked (EDA) Gene NGS Genetic Test in Dubai – 2,800 AED

✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.

✔ Premium Logistics: Hospital-Grade Home Collection (8 AM–11 PM) • VIP Mobile Phlebotomy • Cold-Chain Transport.

✔ Clinical Guidance: Complimentary Post-Test Telephonic Interpretation by a DHA-Certified Consultant Medical Geneticist.

✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Executive Summary & Core Metrics

The EDA gene NGS genetic test detects pathogenic variants in the EDA gene associated with X-linked hypohidrotic ectodermal dysplasia (XLHED), a rare genetic disorder impairing the development of sweat glands, hair, teeth, and skin. This comprehensive sequencing assay covers the entire coding region and splice junctions to confirm clinical diagnoses, guide multidisciplinary management, and inform family planning. The test is typically ordered by dermatologists, clinical geneticists, and pediatricians for patients presenting with characteristic clinical features or a positive family history.

Test Overview & Methodology

This next-generation sequencing (NGS) assay provides full-gene coverage of EDA, including all coding exons, flanking splice sites, and known non-coding regulatory regions. NGS technology delivers superior analytic sensitivity and throughput compared to traditional Sanger sequencing, enabling simultaneous detection of single-nucleotide variants, small insertions/deletions, and larger structural rearrangements with >99.9% accuracy.

NGS vs. Standard Sanger Sequencing

Parameter	Our NGS Test	Standard Sanger Sequencing
Analytic Sensitivity	>99.9%
Method	Next-Generation Sequencing (full gene)
Coverage	All coding exons, splice junctions, known non-coding variants
Turnaround Time	3–4 Weeks

Physician Insight & Safety Protocols

“Comprehensive NGS sequencing of the EDA gene offers definitive molecular confirmation for individuals suspected of X-linked hypohidrotic ectodermal dysplasia. Accurate genotype-phenotype correlation performed by a board-certified medical geneticist is critical to avoid misinterpretation and to provide families with precise recurrence risk counseling and tailored management strategies.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Clinical Advisory & Pretest Considerations

⚠️ Clinical Advisory

This genetic test must be ordered by a licensed physician or certified genetic counselor; direct-to-consumer access is not permitted under UAE regulations.
Pretest genetic counseling is strongly recommended to discuss the implications of potential findings, including carrier status and incidental variants.
Do not discontinue any prescribed medications or treatments based solely on genetic test results without consulting your treating specialist.
For pediatric patients, informed parental consent is required before sample collection.

Emergency Action & Contraindications

🚨 Emergency Action & Exclusion Criteria

If a child with suspected XLHED develops hyperthermia (>38.5°C) due to anhidrosis (inability to sweat), seek emergency medical care immediately. Heatstroke can be life-threatening.
Sample collection should be rescheduled for individuals with acute febrile illness or active skin infection at the venipuncture site.
This test is not designed for prenatal diagnosis without prior comprehensive genetic counseling and multidisciplinary specialist input.

Patient FAQ & Clinical Guidance

1. What does the EDA gene NGS test detect?

This test identifies pathogenic and likely pathogenic variants in the EDA gene responsible for X-linked hypohidrotic ectodermal dysplasia. The assay sequences all coding exons and adjacent splice regions, providing a comprehensive genetic profile that confirms clinical diagnoses, identifies carrier status in at-risk family members, and informs reproductive planning.

2. Who should consider taking this genetic test?

Individuals presenting with clinical signs of hypohidrotic ectodermal dysplasia—such as sparse scalp hair, partial or complete anodontia (missing teeth), hypohidrosis (reduced sweating), and characteristic facial features—are candidates. Those with a confirmed family history of XLHED are also advised to pursue testing after genetic counseling to fully understand the implications of the results.

3. How should I prepare for the home blood collection?

No fasting is necessary. Stay well hydrated and provide the phlebotomist with a complete list of current medications and relevant medical history. For infants, a buccal swab or heel-prick sample may be used as an alternative to venipuncture. Our mobile team follows ISO-certified cold-chain protocols and arrives at your scheduled time window.

UAE Regulatory & Data Privacy Adherence

UAE Regulatory & Data Privacy Compliance

This laboratory service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.

All samples are processed under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Mobile phlebotomy and home collection services are licensed by the Dubai Health Authority. Genetic results are confidential and shared only with the ordering physician and the tested individual or their legal guardian.

Clinical & Logistical Metadata

Test Name	EDA Gene (X-Linked Hypohidrotic Ectodermal Dysplasia) NGS Genetic Test
Price (AED)	2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Peripheral Whole Blood (or Buccal Swab for Infants)
Methodology Used	Next-Generation Sequencing (NGS) – Full Gene Sequencing
ICD-10-CM Code	Q82.4
LOINC Code	81321-2
DHA Facility License & Address	License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE